0001209191-20-018969.txt : 20200313 0001209191-20-018969.hdr.sgml : 20200313 20200313171227 ACCESSION NUMBER: 0001209191-20-018969 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200312 FILED AS OF DATE: 20200313 DATE AS OF CHANGE: 20200313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EMPFIELD JAMES R. CENTRAL INDEX KEY: 0001665430 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36687 FILM NUMBER: 20713882 MAIL ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: VG5 48W ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001582313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980661854 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W BUSINESS PHONE: (604) 484-3300 MAIL ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-12 0 0001582313 Xenon Pharmaceuticals Inc. XENE 0001665430 EMPFIELD JAMES R. 200 - 3650 GILMORE WAY BURNABY A1 BRITISH COLUMBIA, CANADA 0 1 0 0 SVP, Drug Discovery Stock Option (Right to Buy) 11.58 2020-03-12 4 A 0 65000 0.00 A 2030-03-11 Common Shares 65000 65000 D Vesting 25% on January 1, 2021 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. /s/ Cassandra Robinson, Attorney-in-fact 2020-03-13